PL3337487T3 - Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania - Google Patents

Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania

Info

Publication number
PL3337487T3
PL3337487T3 PL16836765T PL16836765T PL3337487T3 PL 3337487 T3 PL3337487 T3 PL 3337487T3 PL 16836765 T PL16836765 T PL 16836765T PL 16836765 T PL16836765 T PL 16836765T PL 3337487 T3 PL3337487 T3 PL 3337487T3
Authority
PL
Poland
Prior art keywords
honocol
magnolol
formulations
application
increased stability
Prior art date
Application number
PL16836765T
Other languages
English (en)
Inventor
Bomi P. Framroze
Original Assignee
St Ip Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Ip Holding Ag filed Critical St Ip Holding Ag
Publication of PL3337487T3 publication Critical patent/PL3337487T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Anesthesiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16836765T 2015-08-17 2016-01-18 Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania PL3337487T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2534DE2015 2015-08-17
PCT/IN2016/050021 WO2017029683A1 (en) 2015-08-17 2016-01-18 Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
EP16836765.4A EP3337487B1 (en) 2015-08-17 2016-01-18 Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof

Publications (1)

Publication Number Publication Date
PL3337487T3 true PL3337487T3 (pl) 2021-12-06

Family

ID=58051448

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16836765T PL3337487T3 (pl) 2015-08-17 2016-01-18 Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania

Country Status (12)

Country Link
US (1) US10328090B2 (pl)
EP (1) EP3337487B1 (pl)
JP (1) JP6663993B2 (pl)
KR (1) KR20180050331A (pl)
AU (2) AU2016308080A1 (pl)
CA (1) CA2995834A1 (pl)
DK (1) DK3337487T3 (pl)
ES (1) ES2873601T3 (pl)
HU (1) HUE054161T2 (pl)
PL (1) PL3337487T3 (pl)
PT (1) PT3337487T (pl)
WO (1) WO2017029683A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3769174B1 (en) 2018-03-21 2022-07-06 Realtime Robotics, Inc. Motion planning of a robot for various environments and tasks and improved operation of same
KR20200083304A (ko) * 2018-12-28 2020-07-08 충북대학교 산학협력단 일본 목련 추출물을 유효성분으로 함유하는 불안장애의 예방 또는 치료용 약학적 조성물
US20220015406A1 (en) * 2019-01-25 2022-01-20 Flaask, Llc Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder
CN110585140A (zh) * 2019-07-08 2019-12-20 苏州海特比奥生物技术有限公司 一种和厚朴酚纳米聚合物胶束冻干制剂及其制备方法
US12213505B2 (en) * 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
WO2025136962A1 (en) * 2023-12-19 2025-06-26 Rebalance Health, Inc. Compositions for reducing hot flashes and symptoms associated with anxiety and formulations thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582735B2 (en) 2000-12-15 2003-06-24 Npi, Llc. Compositions and methods of use for extracts of magnoliaceae plants
CN1723011A (zh) 2002-06-25 2006-01-18 Wm·雷格利Jr·公司 含有厚朴提取物的口气清新和口腔清洁产品
US7632525B2 (en) 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
RU2396941C2 (ru) 2005-12-02 2010-08-20 Джи Ай Си ИННОВАТИОНЗ КОМПАНИ Наполнители с экстрактом коры магнолии для ухода за полостью рта
US7544377B2 (en) 2005-12-02 2009-06-09 Gic Innovations Company Chewable compositions with fast release magnolia bark extract
WO2007064505A1 (en) 2005-12-02 2007-06-07 Gic Innovations Company Confectionary compositions with magnolia bark extract
KR101527829B1 (ko) 2007-04-19 2015-06-12 마리 케이 인코포레이티드 마그놀리아 추출물 함유 조성물
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
DE102010015791A1 (de) * 2010-04-20 2011-10-20 Beiersdorf Ag Wirkstoffkombinationen aus Magnolienrindenextrakt und polyethoxylierten Verbindungen
DE102010015792A1 (de) * 2010-04-20 2011-10-20 Beiersdorf Ag Wirkstoffkombinationen aus Magnolienrindenextrakt und oberflächenaktiven Agentien
RU2606841C2 (ru) * 2010-09-03 2017-01-10 Н.В. Нютрисиа Способ и препарат для лечения или профилактики тревожности или нейрогенеза
FR2970294B1 (fr) * 2011-01-11 2012-12-28 Peugeot Citroen Automobiles Sa Ligne d'echappement pour un moteur a combustion interne
IE20110008A1 (en) 2011-01-12 2012-08-01 Patrick Thomas Prendergast Compositions for alleviating:- stress, anxiety, depression and aiding with weight loss
WO2013043151A1 (en) * 2011-09-19 2013-03-28 Framroze Bomi P Edible oil with a high concentration of poly-unsaturated fatty acids
EP2759065B8 (en) * 2011-09-20 2023-05-03 VivaQuant, Inc. Physiological signal denoising

Also Published As

Publication number Publication date
JP2018528266A (ja) 2018-09-27
JP6663993B2 (ja) 2020-03-13
ES2873601T3 (es) 2021-11-03
KR20180050331A (ko) 2018-05-14
AU2016308080A1 (en) 2018-03-22
AU2022201271A1 (en) 2022-03-17
HUE054161T2 (hu) 2021-08-30
EP3337487A4 (en) 2019-04-03
CA2995834A1 (en) 2017-02-23
US20180147220A1 (en) 2018-05-31
EP3337487A1 (en) 2018-06-27
EP3337487B1 (en) 2021-02-24
PT3337487T (pt) 2021-05-27
DK3337487T3 (da) 2021-05-25
US10328090B2 (en) 2019-06-25
WO2017029683A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
EP3513809A4 (en) MEDICAL COMPOSITION
IL257531A (en) Therapeutic combinations comprising anti-folr1 immunoconjugates
EP3337502A4 (en) STABLE ANTI-IFNAR1 FORMULATION
PT3355990T (pt) Compostos semifluorados e as suas composições
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
HUE066955T2 (hu) Nedvszívó struktúra
EP3065716C0 (en) FORMULATIONS
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
SI4070787T1 (sl) Farmacevtske formulacije
IL256322A (en) Improved formulations of deferasirox and methods of making the same
EP3328353A4 (en) TOPICAL SKIN FORMULATIONS
DK3310340T3 (da) Formulering med høj koncentration
EP3435953A4 (en) COSMETIC MATERIAL COMPOSITIONS
EP3364945C0 (en) SOLID FORMULATION
EP3395325A4 (en) LIQUID COSMETIC COMPOSITION
PT3261437T (pt) Compostos e composições fungicidas
IL258966A (en) Absorbent structure
EP3318245A4 (en) UV-REJECTING COSMETIC COMPOSITION
BR112016027379A2 (pt) formulações tópicas e seus usos
PL3337487T3 (pl) Formulacje honokiolu i magnololu o zwiększonej stabilności i poprawionym wchłanianiu i sposoby ich stosowania
EP3551291A4 (en) COMPOSITION OF DRY SHAMPOO
DK3288640T3 (da) Tørshampoosammensætning
IL264445A (en) Compounds and compositions and uses thereof
EP3328354A4 (en) TOPICAL SKIN FORMULATIONS
DK3316856T3 (da) Blandede formuleringer